Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.
about
A systematic review and meta-analysis of diagnostic and prognostic serum biomarkers of colorectal cancerMACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic reviewA quantitative proteomic approach of the different stages of colorectal cancer establishes OLFM4 as a new nonmetastatic tumor markerTumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.Literature review and practical aspects on the management of oxaliplatin-associated toxicity.Genomic and oncoproteomic advances in detection and treatment of colorectal cancerAdvanced proteomic technologies for cancer biomarker discovery.Tumor infiltrating lymphocytes: an intriguing player in the survival of colorectal cancer patients.Analysis of post-operative changes in serum protein expression profiles from colorectal cancer patients by MALDI-TOF mass spectrometry: a pilot methodological studyImaging and 'omic' methods for the molecular diagnosis of cancer.Integrated analysis of genome-wide copy number alterations and gene expression in microsatellite stable, CpG island methylator phenotype-negative colon cancer.Synuclein gamma predicts poor clinical outcome in colon cancer with normal levels of carcinoembryonic antigenMass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.Serum miR-200c is a novel prognostic and metastasis-predictive biomarker in patients with colorectal cancer.International scientific communications in the field of colorectal tumour markersAllelotyping identification of genomic alterations in rectal chromosomally unstable tumors without preoperative treatment.The density of macrophages in the invasive front is inversely correlated to liver metastasis in colon cancer.Clinical prognostic value of combined analysis of Aldh1, Survivin, and EpCAM expression in colorectal cancerIdentification of MST1/STK4 and SULF1 proteins as autoantibody targets for the diagnosis of colorectal cancer by using phage microarrays.Comprehensive proteome analysis of an Apc mouse model uncovers proteins associated with intestinal tumorigenesis.High expression of testes-specific protease 50 is associated with poor prognosis in colorectal carcinoma.Lymphangiogenesis: a new player in cancer progression.Predictive and prognostic value of circulating nucleosomes and serum biomarkers in patients with metastasized colorectal cancer undergoing Selective Internal Radiation TherapyCirculating miR-221 directly amplified from plasma is a potential diagnostic and prognostic marker of colorectal cancer and is correlated with p53 expression.Current status of long non-coding RNAs in human cancer with specific focus on colorectal cancer.Biomarkers for colorectal cancerUbiquitin D is correlated with colon cancer progression and predicts recurrence for stage II-III disease after curative surgery.Prognostic significance of p53-expression in colorectal carcinoma as measured by a luminometric immunoassayClinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.Serum proteomic profiling for the early diagnosis of colorectal cancer.Prognostic values of chromosome 18q microsatellite alterations in stage II colonic carcinoma.Tumor markers in colorectal cancer, gastric cancer and gastrointestinal stromal cancers: European group on tumor markers 2014 guidelines updateIdentification of phospholipid scramblase 1 as a biomarker and determination of its prognostic value for colorectal cancerExpression of GIV/Girdin, a metastasis-related protein, predicts patient survival in colon cancer.N-glycoprotein SRMAtlas: a resource of mass spectrometric assays for N-glycosites enabling consistent and multiplexed protein quantification for clinical applications.Preoperative serum CA 72.4 as prognostic factor of recurrence and death, especially at TNM stage II, for colorectal cancerEvaluation of eight plasma proteins as candidate blood-based biomarkers for malignant gliomas.Identification of a circulating microRNA signature for colorectal cancer detection.Systematic review of the predictive effect of MSI status in colorectal cancer patients undergoing 5FU-based chemotherapy.
P2860
Q26849247-32AD3599-1DC1-4C97-8779-95D3D4692010Q30157439-A1A1EEC7-E30C-42DB-9A13-6DEC588480B5Q30234900-C3D2FF75-6306-4282-AF1D-FCD28320301DQ31031951-1E1E4B64-5BC1-4F70-9728-CABC9E00FBE2Q33350682-37D4511F-392E-4CA1-AA5F-6B45359F3A83Q33398649-BA683861-F7B1-49FC-8398-F25F6AEAC2D6Q33425477-C61B1092-8BE8-4AB1-9F06-581FD95A7F4CQ33433660-F6F03CA1-C107-4088-AF88-2B89D9EAC3DEQ33552813-B48B8764-38FF-4243-86C0-AA22C73CB7FBQ33564901-428108FA-5007-47F3-8DD0-34B30B67E352Q33577268-2676C6AA-D392-41E3-B585-1E4F29DD4E7EQ33604452-CE05DFCF-0DE4-4DC7-94AC-7358B57428C9Q33626102-F177BC5A-79A0-4744-889A-69A6BA103558Q33651645-1A60522C-AA21-4F55-926D-C7990565EEC8Q33654179-E61D76E4-7471-4769-B38F-09188FFA8504Q33721159-B55A9D72-4AFB-4253-8490-D8D1FA94465BQ33721457-1E91059C-BD9C-471A-9652-CFCFDB05B96AQ33737094-ED2EC1C7-CF9E-44E2-86BA-E1A1564F7E86Q33750119-330A038F-DA1A-4027-BFE6-2F147B6699D0Q33791673-2E490E9A-CE36-4F65-B5C1-67ABAF020349Q33870460-2A1580AE-BA16-4CBF-BE2F-04BD1FDFCDA4Q33963953-23769D37-54E1-4C85-B566-503FF35710BFQ34084937-7D804775-D812-4405-A0BB-682CC9E0F7D1Q34118056-1810F7DA-89FA-419B-A611-920246265D24Q34140780-D78587B8-A1C2-49CC-ABDA-E1282295303AQ34158506-4D41FC5E-6F93-4F60-AD45-CB9138CAEAEBQ34205596-14180A99-2717-486D-B969-BB3F2F3F156FQ34250198-4603903F-35EF-4646-8B82-C1B91E6AB109Q34285565-78E1C820-B0AA-406F-AFE0-D3FB52FA9597Q34362184-BE1838E0-BC47-4143-9F21-7A5C9B85C3D8Q34409534-53BCBA37-2FD1-4D66-BC1C-F3E8A2657D30Q34428763-67AEA9AB-5CA2-4820-ACDB-367A3A9D2BA2Q34441837-F0D2B2FD-10B7-4167-B731-A1AB142C09B5Q34500667-8A7143F3-3B27-48CB-A750-E3641ABAE5E8Q34502681-C2B83D69-C04E-46CC-9902-8C1763DE3D34Q34585592-4ABC7A21-1798-4930-854A-C8CD70730585Q34657343-A2F4A761-77D0-4E47-BB7D-64AA57A177D4Q35067781-F49AD331-B29D-45BD-88D0-02EFA1689764Q35141718-9841CB03-02CF-4F3A-9551-44B17AB6414EQ35224176-BC091F6E-C721-47FA-8115-BCC2F6F47264
P2860
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Tumour markers in colorectal c ...... ) guidelines for clinical use.
@en
type
label
Tumour markers in colorectal c ...... ) guidelines for clinical use.
@en
prefLabel
Tumour markers in colorectal c ...... ) guidelines for clinical use.
@en
P2093
P1476
Tumour markers in colorectal c ...... M) guidelines for clinical use
@en
P2093
Holinski-Feder E
Sturgeon C
van Dalen A
P304
P356
10.1016/J.EJCA.2007.03.021
P577
2007-05-18T00:00:00Z